Immedica Pharma AB, a global leader in rare disease therapies, has announced a definitive agreement to acquire Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) for…
CVS Health has announced plans to eliminate approximately 2,900 corporate roles, representing about 1% of its workforce, as part of a broader strategy…
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for cancer and autoimmune diseases. Using single-cell precision, Orca Bio’s innovative products…